Literature DB >> 15664974

Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions.

Robert K Shaw1, Jennifer Cleary, Michael S Murphy, Gad Frankel, Stuart Knutton.   

Abstract

Enteropathogenic Escherichia coli (EPEC) strains deliver effector proteins Tir, EspB, Map, EspF, EspH, and EspG into host cells to induce brush border remodeling and produce attaching and effacing (A/E) lesions on small intestinal enterocytes. In this study, the role of individual EPEC effectors in brush border remodeling and A/E lesion formation was investigated with an in vitro human small intestinal organ culture model of EPEC infection and specific effector mutants. tir, map, espB, and espH mutants produced "footprint" phenotypes due to close bacterial adhesion but subsequent loss of bacteria; an espB mutant and other type III secretion system mutants induced a "noneffacing footprint" associated with intact brush border microvilli, whereas a tir mutant was able to efface microvilli resulting in an "effacing footprint"; map and espH mutants produced A/E lesions, but loss of bacteria resulted in a "pedestal footprint." An espF mutant produced typical A/E lesions without associated microvillous elongation. An espG mutant was indistinguishable from the wild type. These observations indicate that Tir, Map, EspF, and EspH effectors play a role in brush border remodeling and production of mature A/E lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664974      PMCID: PMC547083          DOI: 10.1128/IAI.73.2.1243-1251.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Role of EspF in host cell death induced by enteropathogenic Escherichia coli.

Authors:  J K Crane; B P McNamara; M S Donnenberg
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

2.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

3.  Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells.

Authors:  B Kenny; R DeVinney; M Stein; D J Reinscheid; E A Frey; B B Finlay
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

4.  Rapid modulation of electrolyte transport in Caco-2 cell monolayers by enteropathogenic Escherichia coli (EPEC) infection.

Authors:  G K Collington; I W Booth; S Knutton
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

5.  Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion.

Authors:  S Knutton; J Adu-Bobie; C Bain; A D Phillips; G Dougan; G Frankel
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  DsbA is required for stability of the type IV pilin of enteropathogenic escherichia coli.

Authors:  H Z Zhang; M S Donnenberg
Journal:  Mol Microbiol       Date:  1996-08       Impact factor: 3.501

7.  Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria.

Authors:  B Kenny; M Jepson
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

8.  EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri.

Authors:  S J Elliott; E O Krejany; J L Mellies; R M Robins-Browne; C Sasakawa; J B Kaper
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.

Authors:  K G Jarvis; J A Girón; A E Jerse; T K McDaniel; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 10.  Intimin and the host cell--is it bound to end in Tir(s)?

Authors:  G Frankel; A D Phillips; L R Trabulsi; S Knutton; G Dougan; S Matthews
Journal:  Trends Microbiol       Date:  2001-05       Impact factor: 17.079

View more
  37 in total

1.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

2.  Interaction of enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence.

Authors:  Francis Girard; Isabelle Batisson; Gad M Frankel; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 3.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells.

Authors:  Robert K Shaw; Katherine Smollett; Jennifer Cleary; Junkal Garmendia; Ania Straatman-Iwanowska; Gad Frankel; Stuart Knutton
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  EspF of enteropathogenic Escherichia coli binds sorting nexin 9.

Authors:  Oliver Marchès; Miranda Batchelor; Robert K Shaw; Amit Patel; Nicola Cummings; Takeshi Nagai; Chihiro Sasakawa; Sven R Carlsson; Richard Lundmark; Celine Cougoule; Emmanuelle Caron; Stuart Knutton; Ian Connerton; Gad Frankel
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

6.  Proteomic analysis of the enterocyte brush border.

Authors:  Russell E McConnell; Andrew E Benesh; Suli Mao; David L Tabb; Matthew J Tyska
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-17       Impact factor: 4.052

7.  EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin Microdomains.

Authors:  Rachana Pattani Ramachandran; Felipe Vences-Catalán; Dan Wiseman; Efrat Zlotkin-Rivkin; Eyal Shteyer; Naomi Melamed-Book; Ilan Rosenshine; Shoshana Levy; Benjamin Aroeti
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Enteropathogenic Escherichia coli O125:H6 triggers attaching and effacing lesions on human intestinal biopsy specimens independently of Nck and TccP/TccP2.

Authors:  Li Bai; Stephanie Schüller; Andrew Whale; Aurelie Mousnier; Olivier Marches; Lei Wang; Tadasuke Ooka; Robert Heuschkel; Franco Torrente; James B Kaper; Tânia A T Gomes; Jianguo Xu; Alan D Phillips; Gad Frankel
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector.

Authors:  Paul Dean; Sabrina Mühlen; Sabine Quitard; Brendan Kenny
Journal:  Cell Microbiol       Date:  2010-03-25       Impact factor: 3.715

10.  Pore-forming Activity of the Escherichia coli Type III Secretion System Protein EspD.

Authors:  Abhishek Chatterjee; Celia Caballero-Franco; Dannika Bakker; Stephanie Totten; Armando Jardim
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.